Radiographic contrast media are widely used in clinical practice. Their use, however, may lead to tissue and organ dysfunction involving thyroid and kidneys especially in patients with renal function already reduced and in those with diabetes. The continued growth in radiographic examinations means that increasing number of patients are exposed to radiographic contrast media, which may result in a high incidence of organ dysfunction associated with their use, being, for instance, the third leading cause of hospital-acquired acute renal failure accounting for 12% of all cases. Hence, there is considerable and evermore growing interest in the prevention of the side effects of these drugs, but unfortunately few pharmacologic interventions have been found to be beneficial.

We particularly take an interest in manuscripts that report the endothelial damage by radiographic contrast media, the effects of radiographic contrast media on thyroid function, the nephrotoxicity of contrast media and the means to prevent it, the effects of contrast media in diabetics and in uremic patients, the hypersensitivity reactions to contrast media, and reviews that summarize the results of clinical trials using contrast media toxicity. Potential topics include, but are not limited to:

• Type of organ dysfunction
• Clinical aspects of organ damage
• Clinical trials of contrast media toxicity
• Mechanisms of tissue and organ damage
• Measures of prevention of organ damage
• Different toxicity of different contrast media

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/bmri/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/bmri/nephrology/rcm/ according to the following timetable: